How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system.

IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Canadian Journal of Urology Pub Date : 2023-12-01
Jean-Nicolas Cornu, Hashim Hashim, Frank Van Der Aa, Cosimo De Nunzio, Valentina Garcia Perez, Roseanne Ferreira, Dean S Elterman
{"title":"How I Do It: Transcutaneous tibial nerve stimulation TENSI+ system.","authors":"Jean-Nicolas Cornu, Hashim Hashim, Frank Van Der Aa, Cosimo De Nunzio, Valentina Garcia Perez, Roseanne Ferreira, Dean S Elterman","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Overactive bladder (OAB) is a common condition that significantly impacts the quality of life (QoL), well-being and daily functioning for both men and women. Among various treatments, peripheral tibial nerve stimulation (PTNS) emerges as an effective third-line treatment for OAB symptoms, with options for either a percutaneous approach (P-PTNS) or by transcutaneous delivery (T-PTNS). Recent studies have shown negligible differences between P-PTNS and T-PTNS efficacy in alleviating urinary urgency and frequency and QoL improvement and, overall no difference in efficacy over antimuscarinic regimens. The TENSI+ system offers a cutting-edge transcutaneous approach, allowing patients to self-administer treatment conveniently at home with electrical stimulation delivery through surface electrodes. It stands out for its ease of preparation, tolerability, and high levels of patient satisfaction. Prospective multicentric data highlights TENSI+ to be an effective and safe treatment for lower urinary tract symptoms with high treatment adherence at 3 months. This paper aims to familiarize readers with the TENSI+ system, current studies, device assembly, operation, and treatment recommendations.</p>","PeriodicalId":56323,"journal":{"name":"Canadian Journal of Urology","volume":"30 6","pages":"11756-11761"},"PeriodicalIF":1.2000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Urology","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Overactive bladder (OAB) is a common condition that significantly impacts the quality of life (QoL), well-being and daily functioning for both men and women. Among various treatments, peripheral tibial nerve stimulation (PTNS) emerges as an effective third-line treatment for OAB symptoms, with options for either a percutaneous approach (P-PTNS) or by transcutaneous delivery (T-PTNS). Recent studies have shown negligible differences between P-PTNS and T-PTNS efficacy in alleviating urinary urgency and frequency and QoL improvement and, overall no difference in efficacy over antimuscarinic regimens. The TENSI+ system offers a cutting-edge transcutaneous approach, allowing patients to self-administer treatment conveniently at home with electrical stimulation delivery through surface electrodes. It stands out for its ease of preparation, tolerability, and high levels of patient satisfaction. Prospective multicentric data highlights TENSI+ to be an effective and safe treatment for lower urinary tract symptoms with high treatment adherence at 3 months. This paper aims to familiarize readers with the TENSI+ system, current studies, device assembly, operation, and treatment recommendations.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
我的方法:经皮胫神经刺激 TENSI+ 系统。
膀胱过度活动症(OAB)是一种常见疾病,严重影响着男性和女性的生活质量(QoL)、幸福感和日常功能。在各种治疗方法中,胫骨外周神经刺激疗法(PTNS)是治疗膀胱过度活动症的有效三线疗法,可选择经皮方法(P-PTNS)或经皮给药方法(T-PTNS)。最近的研究表明,P-PTNS 和 T-PTNS 在缓解尿急、尿频和改善 QoL 方面的疗效差异微乎其微,总体上与抗心绞痛药物疗效没有差异。TENSI+ 系统提供了一种先进的经皮治疗方法,患者可以在家中通过表面电极进行电刺激,方便地进行自我治疗。该系统因其准备简便、耐受性好、患者满意度高而脱颖而出。前瞻性多中心数据显示,TENSI+ 是治疗下尿路症状的有效且安全的方法,3 个月的治疗依从性很高。本文旨在让读者熟悉 TENSI+ 系统、当前研究、设备组装、操作和治疗建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Canadian Journal of Urology
Canadian Journal of Urology UROLOGY & NEPHROLOGY-
CiteScore
1.90
自引率
0.00%
发文量
86
审稿时长
6-12 weeks
期刊介绍: The CJU publishes articles of interest to the field of urology and related specialties who treat urologic diseases.
期刊最新文献
Single-port robotic laparoscopic ureterocalicostomy: surgical technique and clinical outcomes. Clinical implications of tumor laterality in renal cell carcinoma. Hypogonadism, frailty, and postoperative outcomes among men undergoing partial nephrectomy. Illuminating the use of photodynamic therapy in urologic oncology. Legends in Urology v31I06.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1